The 2025-2030 World Outlook for Exosome Diagnostic and Therapeutics - Image 1

Out of stock

This item is currently unavailable

The 2025-2030 World Outlook for Exosome Diagnostic and Therapeutics

Subjects

Out of stock

Price data last checked 19 day(s) ago - will refresh soon

View at Amazon

One email. No newsletter. No nudges.

Gone for 273 days. Could come back at any time — we're watching for you.

Out of stock 273 days · last price £790 · longest previous gap was 1 days

NEW HERE?

Amazon shows you one price. We show you all of them.

Tosheroon watches Amazon prices so you don't have to. Every product on Amazon has a price history — we make it visible. Set the price you'd actually pay, and we'll email you the second it gets there. No app, no account, one email.

WHAT'S ON THIS PAGE

↓ Price chart
when this has been cheap or pricey

↓ Forecast
where the price is heading next

↓ Statistics
all-time high & low, recent range

↑ Price alert
name your number, we'll email you

Price History & Forecast

Grey patches = out of stock. Cheaper = lower on the chart. Hover for exact prices.

Last 499 days · 499 data points (no recent data)

Historical

Generating forecast…

Price Distribution

Price distribution over 499 days • 1 price levels

Days at Price

Price Analysis

Most common price: £790 (499 days, 100.0%)

Price range: £790 - £790

Price levels: 1 different prices over 499 days

Description

This study covers the world outlook for exosome diagnostic and therapeutics across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. These comparative benchmarks allow the reader to quickly gauge a country vis-à-vis others. Using econometric models which project fundamental economic dynamics within each country and across countries, latent demand estimates are created. This report does not discuss the specific players in the market serving the latent demand, nor specific details at the product level. The study also does not consider short-term cyclicalities that might affect realized sales. The study, therefore, is strategic in nature, taking an aggregate and long-run view, irrespective of the players or products involved. In this report we define the sales of exosome diagnostic and therapeutics as including all commonly understood products and/or services falling within this broad category, irrespective of product packaging, formulation, size, or form. Companies participating in this industry include Aethlon Medical, Inc. (U.S.), Bio-Rad Laboratories, Capricor THERAPEUTICS (U.S.), Codiak BioSciences, Evox Therapeutics, Exiqon A/S (Denmark), Exiqun A/S, Exosome Diagnostics, Expedeon, Fluidigm, HansaBioMed Life Sciences Ltd. (Lonza), JN Medsys, Malvern Instruments, Merck KGaA., NanoSomix Inc. (U.S.), NonoSomiX, NX Pharmagen, Qiagen, Sistemic Inc. (U.K.), Stilla Technologies, Sysmex Corporation, System Biosciences, and Thermo Fisher Scientific. In addition to the sources indicated, additional information available to the public via news and/or press releases published by players in the industry was considered in defining and calibrating this category. All figures are in a common currency (U.S. dollars, millions) and are not adjusted for inflation (i.e., they are current values). Exchange rates used to convert to U.S. dollars are averages for the year in question. Future exchange rates are assumed to be constant in the future at the current level (the average of the year of this publication's release in 2024).

Product Specifications

Format: paperback
ASIN: B0CZ2FDR2M
Category: Books > Subjects
Domain: Amazon UK
Release Date: 03 March 2024
Listed Since: 24 April 2024

The 2025-2030 World Outlook for Exosome Diagnostic and Therapeutics

Gone for 273 days. Could come back at any time — we're watching for you.

Price History & Forecast

Price Distribution

Price Analysis

Description

Product Specifications

Similar Products You Might Like

The 2025-2030 World Outlook for Exosome Therapeutics

The 2025-2030 World Outlook for Exosome Industries

The 2025-2030 World Outlook for Exosomes

The 2023-2028 World Outlook for Exosome Therapeutics

The 2023-2028 World Outlook for Exosome Industries

The 2023-2028 World Outlook for Exosomes

Exosome Therapies: From Bench to Bedside in Chronic Disease

Exosomes - Recent Advances From Bench to Bedside: 20 (Physiology)

Global Exosome Trials

The 2026-2031 World Outlook for Exosomes

Stem Cell-Derived Exosomes and Microvesicles: Clinical Applications (Stem Cells in Clinical Applications)

The 2021-2026 World Outlook for Exoskeletons

Exosomes in Cardiovascular Diseases: Biomarkers, Pathological and Therapeutic Effects: 998 (Advances in Experimental Medicine and Biology, 998)

The 2025-2030 World Outlook for Whole Exome Sequencing Systems

The 2026-2031 World Outlook for Medical Exoskeletons

The 2023-2028 World Outlook for Medical Exoskeletons

The 2025-2030 World Outlook for Whole Exome Sequencing

Unlocking the Secrets of Extracellular Vesicles and Exosomes: A Journey into the Cutting-Edge Frontier of Cellular Communication

The 2026-2031 World Outlook for Exoskeletons

Exosomes and MicroRNAs in Biomedical Science (Synthesis Lectures on Biomedical Engineering)

The 2023-2028 World Outlook for Smart Exoskeletons

The 2026-2031 World Outlook for Smart Exoskeletons

The 2025-2030 World Outlook for Life Science Products

The 2021-2026 World Outlook for Mesenchymal Stem Cells (MSC)